Obesity may slow progress against cancer deaths 

May 12, 2021
Cancer death rates have fallen dramatically in the United States. Factor in obesity, however — as Gillings School researchers did, and the picture changes. A study published May 10 in JAMA Network Open reports that obesity-related cancer deaths are improving, but at a slowing pace.

“Geography of risk” impacts analysis of racial inequities in COVID-19 deaths

April 5, 2021
In a new commentary, Gillings School epidemiologists call for an approach to monitoring COVID-19 data that compares risks across racial and ethnic demographics in order to create a more equitable response to the pandemic.

New ozone air pollution maps support Global Burden of Disease study

March 8, 2021
New research led by UNC Gillings School students and faculty has mapped global ground-level ozone concentrations by year using a data fusion. This is the first time this method has been applied to ozone observations globally. The findings were used by the Global Burden of Disease 2019 study, which estimated that about 365,000 people around the world died in 2019 from exposure to ozone pollution.

New dashboard estimates number of NC residents eligible for each vaccine phase

February 23, 2021
As North Carolina prepares to enter Phase 3 of COVID-19 vaccine distribution, the North Carolina Institute for Public Health has created a set of dashboards to assist local planning by providing valid population estimates for the phased distribution of the vaccine in the state.

Activity trackers may help patients maintain physical activity after cardiac rehabilitation discharge

February 4, 2021
A new study that includes research from Dr. Kelly Evenson suggests that activity trackers could help patients maintain necessary levels of physical activity after they are discharged from outpatient cardiac rehabilitation.

Study shows new machine learning method may lead to optimal cancer treatment decisions

December 4, 2020
Researchers at the University of North Carolina at Chapel Hill and North Carolina State University have developed a computational framework to generate evidence-based optimal cancer treatment decisions informed by a patient’s genomic biomarkers. The findings, which may aid in the development of precision cancer treatments, are published in the Journal of the American Statistical Association.

ACS/Pfizer grant funds research into racial disparities in breast cancer care quality in North Carolina

December 3, 2020
The grant is part of a national campaign focused on optimizing cancer outcomes for people of color by identifying and eliminating systemic race-related barriers and disparities in the delivery of care that impact outcomes across all cancer types.

PCORI funds UNC research to assess representativeness of COVID-19 treatment trials

November 16, 2020
The Patient-Centered Outcomes Research Institute is funding research at the Gillings School to compare how participants in COVID-19 clinical trials differ from real-world patients infected with the virus.

North Carolina sees highest estimates to-date in prevalence of autism spectrum disorder in 8-year-olds

June 25, 2020
The 2020 Community Report on Autism from the Centers for Disease Control and Prevention, which includes research from Dr. Julie Daniels, has found that the prevalence of autism spectrum disorder detected in 8-year-olds in North Carolina was significantly higher than the national average. It also found that the prevalence detected in 4-year-olds was lower.

The Gillings Community Responds to COVID-19: Tracking the Spread

May 18, 2020
The asymptomatic transmission of COVID-19 has created a significant challenge for public health experts. Learn how faculty and alumni in epidemiology, health behavior and biostatistics are working to track the spread of the disease through studies, contact tracing, modeling and more.

...
2
3
4
1
5
6
7
8
...
RELATED PAGES
CONTACT INFORMATION
Visit our communications and marketing team page.
Contact sphcomm@unc.edu with any media inquiries or general questions.

Communications and Marketing Office
125 Rosenau Hall
CB #7400
135 Dauer Drive
Chapel Hill, NC 27599-7400